Cea-Soriano L, et al. - Researchers explored the link between use of non-insulin antidiabetics in early pregnancy and the risk of miscarriages, stillbirths and major structural malformations. Using electronic medical records from The Health Improvement Network (THIN), a cohort of 1511 pregnant women with pre-gestational diabetes linked to live births were identified for the period 1995 to 2012. It was observed in the findings that use of non-insulin antidiabetics early in pregnancy was not correlated with greater risks of foetal losses or major malformations than was insulin among women with diabetes.